Wu Ping-ping, Jin Yue-ling, Shang Yan-fang, Jin Zhi, Wu Peng, Huang Pei-lin
Department of Oncology, Medical College, Southeast University, Nanjing 210009, China.
Ann Clin Lab Sci. 2009 Summer;39(3):263-9.
DLC1 (deleted in liver cancer-1) is a new candidate tumor suppressor gene, which is inactive in various types of human cancers including colon cancer. To study the function of DLC1, we constructed a pcDNA3.1 vector containing the DLC1 gene and transfected it into HT29 colon cancer cells that were deficient in DLC1 expression. The restoration of DLC1 expression in HT29 cells significantly inhibited cell proliferation and migration. Flow cytometry showed that DLC1 transfection into HT29 cells induced apoptosis and that the cell cycle was arrested at S-phase. Additionally, cyclinD1 mRNA and protein expression were down-regulated while p21 expression was increased in pcDNA3.1-DLC1-HT29 cells compared to wild HT29 cells. These results confirm the role of DLC1 gene as a tumor suppressor, which may be manifested by regulation of p21 and cyclinDl. The DLC1 gene has a potential therapeutic role in inhibiting the development of colon cancer.
肝癌缺失基因1(DLC1)是一种新的候选肿瘤抑制基因,在包括结肠癌在内的多种人类癌症中呈失活状态。为了研究DLC1的功能,我们构建了一个包含DLC1基因的pcDNA3.1载体,并将其转染到DLC1表达缺失的HT29结肠癌细胞中。HT29细胞中DLC1表达的恢复显著抑制了细胞增殖和迁移。流式细胞术显示,将DLC1转染到HT29细胞中可诱导细胞凋亡,且细胞周期停滞于S期。此外,与野生型HT29细胞相比,pcDNA3.1-DLC1-HT29细胞中细胞周期蛋白D1的mRNA和蛋白表达下调,而p21表达上调。这些结果证实了DLC1基因作为肿瘤抑制基因的作用,其可能通过调节p21和细胞周期蛋白D1来体现。DLC1基因在抑制结肠癌发展方面具有潜在的治疗作用。